Vanguard Group Inc Liquidia Corp Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Liquidia Corp stock. As of the latest transaction made, Vanguard Group Inc holds 3,593,558 shares of LQDA stock, worth $86.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,593,558
Previous 3,466,640
3.66%
Holding current value
$86.6 Million
Previous $51.1 Million
12.43%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LQDA
# of Institutions
201Shares Held
47.1MCall Options Held
475KPut Options Held
527K-
Black Rock Inc. New York, NY4.24MShares$102 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.99MShares$96.2 Million0.34% of portfolio
-
Findell Capital Management LLC New York, NY2.89MShares$69.6 Million20.5% of portfolio
-
Opaleye Management Inc. Boston, MA2.26MShares$54.5 Million9.17% of portfolio
-
State Street Corp Boston, MA1.79MShares$43.1 Million0.0% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.55B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...